I
106TH CONGRESS
2D SESSION
H. R. 5427
To reauthorize the Drug-Free Communities Act, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
OCTOBER 10, 2000
Mr. PORTMAN (for himself and Mr. LEVIN) introduced the following bill;
which was referred to the Committee on Government Reform, and in ad-
dition to the Committee on Commerce, for a period to be subsequently
determined by the Speaker, in each case for consideration of such provi-
sions as fall within the jurisdiction of the committee concerned
A BILL
To reauthorize the Drug-Free Communities Act, and for
other purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. DRUG-FREE COMMUNITIES SUPPORT PRO-
GRAM.
(a) SHORT TITLE.—Chapter 2 of the National Nar-
cotics Leadership Act of 1988 (21 U.S.C. 1521 et seq.),
(referred to in this section as ‘‘the Act’’) is amended by
inserting after the chapter heading the following:
‘‘SEC. 1020. SHORT TITLE.
‘‘This chapter may be cited as the ‘Drug-Free Com-
munities Act’.’’.
(b) EXTENSION AND INCREASE IN PROGRAM.—Sec-
tion 1024(a) of the Act (21 U.S.C. 1524(a)) is amended—
(1) by striking ‘‘and’’ at the end of paragraph
(4);
(2) by striking the period at the end of para-
graph (5) and inserting a semicolon; and
(3) by adding at the end the following new
paragraphs:
‘‘(6) $55,000,000 for fiscal year 2003;
‘‘(7) $60,000,000 for fiscal year 2004;
‘‘(8) $65,000,000 for fiscal year 2005; and
‘‘(9) $70,000,000 for fiscal year 2006.’’.
(c) ADMINISTRATIVE COSTS.—Section 1024(b) of the
Act (21 U.S.C. 1524(b)) is amended by striking ‘‘amounts
authorized’’ and inserting ‘‘amounts made available’’.
(d) EXTENSION OF LIMITATION ON ADMINISTRATIVE
COSTS.—Section 1024(b) of the Act (21 U.S.C. 1524(b))
is amended by adding at the end the following new para-
graph:
‘‘(6) 3 percent for each of fiscal years 2003
through 2006.’’.
(e) MODIFICATION OF AMOUNT FOR GRANT RENEW-
ALS.—Section 1032 of the Act (21 U.S.C. 1532) is
amended—
(1) by striking clause (iv) of subsection
(b)(1)(A) and inserting the following:
‘‘(iv) LIMITATIONS.—
‘‘(I) FUNDING LEVELS.—Except
as provided in subclause (II), the
amount of a grant award under this
subparagraph 
may 
not 
exceed
$100,000 for a fiscal year. In the sec-
ond year of the grant award period,
upon successful reapplication, a grant
recipient is eligible to maintain its
funding level at 100 percent of the
original award. In the third year of
the grant award period, upon success-
ful reapplication, a grant recipient is
eligible to maintain its funding level
at 75 percent of the original award.
In the fourth and fifth years of the
grant award period, upon successful
reapplication, a grant recipient is eli-
gible to maintain its funding level at
50 percent of the original award.
‘‘(II) EXCEPTIONS.—Any grant
recipient 
receiving 
an 
award 
of
$50,000 or less is eligible in a subse-
quent fiscal year of the grant award
period, upon successful reapplication,
to receive not less than that amount.
A grant recipient receiving an award
amount greater than $50,000 and
successfully reapplying for a grant
award shall not have its funding level
reduced below $50,000 in any subse-
quent fiscal year of the grant award
period.’’; and
(2) by adding at the end the following new sub-
section:
‘‘(c) MODIFICATION OF ELIGIBILITY CRITERIA.—The
Administrator may not implement any modification in the
criteria specified in subsection (a) for eligibility for the
renewal of a grant award under this section without con-
sulting the Advisory Commission.’’.
SEC. 2. REPORTING REQUIREMENTS.
(a) STUDY.—The Director of the Office of National
Drug Control Policy shall conduct a study that evaluates
the need, if any, to increase administrative costs for the
Drug-Free Communities Act (referred to in this section
as ‘‘the Act’’).
(b) REPORT.—After the completion of the study de-
scribed in subsection (a), but not later than 90 days after
the date of the enactment of this Act, the Director shall
submit to Congress a report that includes the findings of
such study and—
(1) information regarding current staffing levels
and administrative requirements necessary to carry
out the Act;
(2) the necessity, if any, and justification of an
increase in administrative funds, including the
amount of such increase, to carry out the Act;
(3) what programs or activities any proposed
increase will support and a description of how such
programs or activities will improve grant perform-
ance, application processing, grant administration,
and program support, including support for the Ad-
visory Commission established under the Act;
(4) a specific accounting of the amount or per-
centage of any such increase which will be used by
Federal agencies involved in administering or sup-
porting the program established under the Act; and
(5) an analysis of expected outcomes if adminis-
trative funds are increased and what measures the
Director and the Attorney General will take to limit
administrative costs in the future.
SEC. 3. ANTIDRUG COALITION INSTITUTE.
(a) IN GENERAL.—The Director of the Office of Na-
tional Drug Control Policy may make grants to an organi-
zation to provide for the establishment of a National Com-
munity Antidrug Coalition Institute.
(b) REQUIREMENTS.—The organization receiving a
grant under subsection (a) shall—
(1) be a national nonprofit organization that
represents, provides technical assistance and train-
ing to, and has special expertise and broad, national-
level experience in community antidrug coalitions;
and
(2) establish a National Community Antidrug
Coalition Institute that will—
(A) provide education, training, and tech-
nical assistance for coalition leaders and com-
munity teams;
(B) conduct research, testing, and diffu-
sion of tools, mechanisms, and measures to bet-
ter evaluate and document coalition perform-
ance measures and outcomes; and